- 专利标题: INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS
-
申请号: US18236215申请日: 2023-08-21
-
公开(公告)号: US20240148643A1公开(公告)日: 2024-05-09
- 发明人: Michael R. Robinson , James A. Burke , Rhett M. Schiffman , Alazar N. Ghebremeskel
- 申请人: Allergan, Inc.
- 申请人地址: US CA Irvine
- 专利权人: Allergan, Inc.
- 当前专利权人: Allergan, Inc.
- 当前专利权人地址: US CA Irvine
- 分案原申请号: US14031657 2013.09.19
- 主分类号: A61K9/00
- IPC分类号: A61K9/00 ; A61K9/16 ; A61K31/5575 ; A61K47/10 ; A61K47/34 ; A61L27/18 ; A61L27/54 ; A61L27/58
摘要:
Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.
信息查询